US Patent 10485855 Demonstrable efficacy across or within patient populations
Patent 10485855 was granted and assigned to Anterios on November, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+501 characters)
Article
Patent abstract
The present invention provides methods for improving observed or determined efficacy by administration of agents to more severely diseased subjects, as contrasted with less severely diseased subjects. The present disclosure specifically demonstrates that, with respect to treatment of certain skin conditions, and particularly conditions associated with dysregulated and/or diseased skin cells, administration to more severely diseased subjects improves observed or determined efficacy.
Edits on 3 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Jonathan Edelson0
Edits on 24 Mar, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 27 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 19 May, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 30 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10485855 Demonstrable efficacy across or within patient populations
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10485855
Date of patent
November 26, 2019
Patent application number
14702269
Date Filed
May 1, 2015
Patent primary examiner
Find more entities like US Patent 10485855 Demonstrable efficacy across or within patient populations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
